ITMI20000628A1 - COSMETIC COMPOSITIONS DELAYING THE GROWTH OF THE HAIR - Google Patents
COSMETIC COMPOSITIONS DELAYING THE GROWTH OF THE HAIR Download PDFInfo
- Publication number
- ITMI20000628A1 ITMI20000628A1 IT2000MI000628A ITMI20000628A ITMI20000628A1 IT MI20000628 A1 ITMI20000628 A1 IT MI20000628A1 IT 2000MI000628 A IT2000MI000628 A IT 2000MI000628A IT MI20000628 A ITMI20000628 A IT MI20000628A IT MI20000628 A1 ITMI20000628 A1 IT MI20000628A1
- Authority
- IT
- Italy
- Prior art keywords
- phospholipids
- vasoprotective
- cosmetic compositions
- extract
- complex
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 49
- 239000002537 cosmetic Substances 0.000 title claims description 22
- 239000000284 extract Substances 0.000 claims description 27
- 210000004209 hair Anatomy 0.000 claims description 24
- 150000003904 phospholipids Chemical class 0.000 claims description 17
- 240000006661 Serenoa repens Species 0.000 claims description 14
- 235000005318 Serenoa repens Nutrition 0.000 claims description 14
- 230000002666 vasoprotective effect Effects 0.000 claims description 13
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 9
- 240000001980 Cucurbita pepo Species 0.000 claims description 7
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 7
- 240000006365 Vitis vinifera Species 0.000 claims description 7
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 7
- 244000194101 Ginkgo biloba Species 0.000 claims description 6
- 240000000353 Ruscus aculeatus Species 0.000 claims description 6
- 235000003500 Ruscus aculeatus Nutrition 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 244000089698 Zanthoxylum simulans Species 0.000 claims description 5
- 230000003501 anti-edematous effect Effects 0.000 claims description 5
- 235000002532 grape seed extract Nutrition 0.000 claims description 5
- 229930182490 saponin Natural products 0.000 claims description 5
- 235000017709 saponins Nutrition 0.000 claims description 5
- 150000007949 saponins Chemical class 0.000 claims description 5
- 241000157282 Aesculus Species 0.000 claims description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 4
- 230000000979 retarding effect Effects 0.000 claims description 4
- UEERCCUVEABBNG-UHFFFAOYSA-N Arjunglucoside I Chemical compound CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(CO)C5CCC34C)C2C1O)C(=O)OC1OC(CO)C(O)C(O)C1O UEERCCUVEABBNG-UHFFFAOYSA-N 0.000 claims description 3
- 241000233910 Serenoa Species 0.000 claims description 3
- KWHJLXOOXXSARN-UHFFFAOYSA-N Sericoside Natural products CC1C(O)C(O)C(CO)OC1OC23CCC(C)(C)C(O)C2C4=CCC5C6(C)CC(O)C(O)C(C)(CO)C6CCC5(C)C4(C)CC3 KWHJLXOOXXSARN-UHFFFAOYSA-N 0.000 claims description 3
- 229930182558 Sterol Natural products 0.000 claims description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 3
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000000202 analgesic effect Effects 0.000 claims description 3
- CMZFNIMQBCBHEX-UHFFFAOYSA-N arjunglucoside I Natural products C1CC(C2(CCC3C(C)(CO)C(O)C(O)CC3(C)C2CC=2)C)(C)C=2C2C(O)C(C)(C)CCC21C(=O)OC1OC(CO)C(O)C(O)C1O CMZFNIMQBCBHEX-UHFFFAOYSA-N 0.000 claims description 3
- WKKBYJLXSKPKSC-UHFFFAOYSA-N niga-ichigoside F2 Natural products C1CC(C2(CCC3C(C)(CO)C(O)C(O)CC3(C)C2CC=2)C)(C)C=2C2C(O)(C)C(C)CCC21C(=O)OC1OC(CO)C(O)C(O)C1O WKKBYJLXSKPKSC-UHFFFAOYSA-N 0.000 claims description 3
- 229950005143 sitosterol Drugs 0.000 claims description 3
- 150000003432 sterols Chemical class 0.000 claims description 3
- 235000003702 sterols Nutrition 0.000 claims description 3
- 235000011201 Ginkgo Nutrition 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 241000408747 Lepomis gibbosus Species 0.000 claims description 2
- 235000018639 Terminalia sericea Nutrition 0.000 claims description 2
- 241000844454 Terminalia sericea Species 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 230000002280 anti-androgenic effect Effects 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 235000010181 horse chestnut Nutrition 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 235000020236 pumpkin seed Nutrition 0.000 claims description 2
- 150000003505 terpenes Chemical class 0.000 claims description 2
- 235000007586 terpenes Nutrition 0.000 claims description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims 4
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims 2
- 229960003720 enoxolone Drugs 0.000 claims 2
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 claims 1
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 claims 1
- 239000008139 complexing agent Substances 0.000 claims 1
- 150000003648 triterpenes Chemical class 0.000 claims 1
- 238000009472 formulation Methods 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 8
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 8
- 229940100530 zinc ricinoleate Drugs 0.000 description 8
- 239000002304 perfume Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 6
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 6
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 230000002951 depilatory effect Effects 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 235000010384 tocopherol Nutrition 0.000 description 6
- 229960001295 tocopherol Drugs 0.000 description 6
- 229930003799 tocopherol Natural products 0.000 description 6
- 239000011732 tocopherol Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 6
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 229940075529 glyceryl stearate Drugs 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 229940073669 ceteareth 20 Drugs 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000007764 o/w emulsion Substances 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- -1 xanthanum Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 2
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N alpha-mercaptoacetic acid Natural products OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- 229940011399 escin Drugs 0.000 description 2
- 229930186222 escin Natural products 0.000 description 2
- 230000003659 hair regrowth Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229940095127 oleth-20 Drugs 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- SBZWTSHAFILOTE-SOUVJXGZSA-N (2R,3S,4S)-leucocyanidin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3[C@H](O)[C@@H]2O)=CC=C(O)C(O)=C1 SBZWTSHAFILOTE-SOUVJXGZSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 210000004883 areola Anatomy 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 229940031661 dimethicone 350 Drugs 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000008389 polyethoxylated castor oil Substances 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 230000003966 vascular damage Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000004018 waxing Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Description
Descrizione dell'invenzione industriale avente per titolo: "COMPOSIZIONI COSMETICHE RITARDANTI LA RICRESCITA DEI PELI SUPERFLUI " Description of the industrial invention entitled: "COSMETIC COMPOSITIONS DELAYING THE REGROWTH OF SUPERFLUOUS HAIR"
La presente invenzione si riferisce al campo della cosmetica . The present invention relates to the field of cosmetics.
Più precisamente, la presente invenzione ha per oggetto composizioni cosmetiche ritardanti la ricrescita dei peli superflui . More precisely, the present invention relates to cosmetic compositions which retard the regrowth of unwanted hair.
SFONDO TECNICO TECHNICAL BACKGROUND
Nel genere umano le caratteristiche principali relative allo sviluppo di peli (numero, colore, spessore, lunghezza, distribuzione) sono conseguenza di un'azione mediata dagli ormoni sessuali a sua volta frutto di un'espressione genica. In mankind, the main characteristics relating to the development of hair (number, color, thickness, length, distribution) are the consequence of an action mediated by sex hormones, which in turn is the result of a gene expression.
Nella maggior parte delle società socio-economicamente sviluppate, i peli delle estremità, del cavo ascellare, quelli pubici che possono fuoriuscire dalla linea del costume da bagno o quelli che, pur raramente, crescono intorno all'areola mammaria, vengono considerati inestetici per la donna. Il termine "peli superflui" tende proprio ad indicare la crescita della peluria di queste aree. Essendo ovviamente tali peli superflui "indesiderati", sono nate le cosiddette pratiche di epilazione (rimozione dell'intero pelo mediante ceretta o diatermocoagulazione) e depilazione (rimozione del pelo a partire dallo sbocco cutaneo mediante distribuzione chimica della cheratina, rasatura con lame, rasatura elettrica o traumatismo ripetuto del pelo). In most socio-economically developed societies, hair from the extremities, the axillary cavity, pubic hair that can come out of the swimsuit line or that, although rarely, grows around the mammary areola, are considered unsightly for the woman. . The term "unwanted hair" tends to indicate the growth of hair in these areas. Since these unwanted hairs are obviously "unwanted", the so-called epilation practices (removal of the entire hair by waxing or diathermocoagulation) and depilation (removal of the hair starting from the cutaneous outlet by chemical distribution of keratin, shaving with blades, electric shaving or repeated trauma of the hair).
Poiché tutte queste pratiche sono, almeno in parte, traumatiche per la cute, prò-infiammanti per i tessuti immediatamente sottostanti la cute interessata e vasolesive per capillari e venule periferiche, nasce la necessità, sia nella post-epilazione che nella post -depilazione, di limitare tali conseguenze oltre che, ovviamente, di ritardare il più possibile la ricrescita dei peli superflui rimossi . Since all of these practices are, at least in part, traumatic for the skin, pro-inflammatory for the tissues immediately underlying the affected skin and vascular damage for capillaries and peripheral venules, there is a need, both in post-epilation and post-epilation, for limit these consequences as well as, of course, delay as much as possible the regrowth of unwanted hair removed.
La presente invenzione ha per oggetto composizioni cosmetiche ad azione ritardante la ricrescita dei peli superflui . The present invention relates to cosmetic compositions with a retarding action on the regrowth of unwanted hair.
Più particolarmente, la presente invenzione ha per oggetto composizioni cosmetiche contenenti acidi grassi e steroli antiandrogeni da serenoa (Serenoa repens) e/o da semi di zucca (Cucurbita pepo). More particularly, the present invention relates to cosmetic compositions containing fatty acids and antiandrogenic sterols from serenoa (Serenoa repens) and / or from pumpkin seeds (Cucurbita pepo).
Le composizioni dell'invenzione possono contenere tali componenti allo stato puro oppure estratti che li contengono, in quantità da 0.1 a 3.0%. The compositions of the invention can contain such components in the pure state or extracts containing them, in quantities ranging from 0.1 to 3.0%.
Secondo un aspetto preferito, la presente invenzione ha per oggetto composizioni cosmetiche contenenti inoltre agenti antinfiammatori e/o vasoprotettivi. According to a preferred aspect, the present invention relates to cosmetic compositions further containing anti-inflammatory and / or vasoprotective agents.
Secondo un ulteriore aspetto preferito, la presente invenzione ha per oggetto composizioni cosmetiche contenenti agenti antinfiammatori e/o vasoprotettivi scelti fra: According to a further preferred aspect, the present invention relates to cosmetic compositions containing anti-inflammatory and / or vasoprotective agents selected from:
- triterpeni ad attività antinfiammatoria da liquirizia (Glycyrrhiza glabra); - triterpenes with anti-inflammatory activity from licorice (Glycyrrhiza glabra);
- saponine antiedematose e antinfiammatorie da ippocastano (Aesculus hyppocastanum); - anti-edematous and anti-inflammatory saponins from horse chestnut (Aesculus hyppocastanum);
- triterpeni da Terminalia sericea; - triterpenes from Terminalia sericea;
- isobutilammidi ad azione antalgica e antiedematosa da Zanthoxylum bungeanum (sin Alatum); - isobutylamides with analgesic and anti-edematous action from Zanthoxylum bungeanum (sin Alatum);
- gingkoflavonglucosidi e terpeni vasoprotettivi da ginkgo (Ginkgo biloba); - gingkoflavonglucosides and vasoprotective terpenes from ginkgo (Ginkgo biloba);
- polifenoli vasoprotettivi da semi d'uva (Vitis vinifera); - antocianosidi vasoprotettivi da mirtillo bacche (Vaccinium myrtillus) ; - vasoprotective polyphenols from grape seeds (Vitis vinifera); - vasoprotective anthocyanosides from blueberry berries (Vaccinium myrtillus);
- saponine vasoprotettive da pungitopo (Ruscus aculeatus). - vasoprotective saponins from butcher's broom (Ruscus aculeatus).
Queste composizioni preferite dell 'invenzione possono contenere i componenti sopra elencati allo stato puro oppure estratti che li contengono, in quantità da 0.1 a 3.0%. These preferred compositions of the invention can contain the components listed above in the pure state or extracts which contain them, in quantities ranging from 0.1 to 3.0%.
Tutti i derivati sopra elencati possono essere eventualmente complessati con veicolanti capaci di migliorarne l'assorbimento e l'efficacia, in particolare fosfolipidi . All the above listed derivatives can optionally be complexed with carriers capable of improving their absorption and efficacy, in particular phospholipids.
I derivati vegetali sopra elencati, come pure procedimenti per la loro preparazione, sono noti, tra l'altro, da US 5,547,673, WO 00/02570, EP 0,283,713, EP 0,250,953, EP 0,275,224. The plant derivatives listed above, as well as processes for their preparation, are known, inter alia, from US 5,547,673, WO 00/02570, EP 0,283,713, EP 0,250,953, EP 0,275,224.
E' noto, dalla tecnica precedente, che tali derivati sono dotati di attività antinfiammatorie, analgesiche, vasotoniche, antiedematose, vasoprotettrici, tonificanti, che li rendono utili nel trattamento di condizioni infiammatorie e di vasculopatie in presenza o meno di fragilità capillare. It is known, from the prior art, that such derivatives are endowed with anti-inflammatory, analgesic, vasotonic, anti-edematous, vasoprotective, toning activities, which make them useful in the treatment of inflammatory conditions and vasculopathies in the presence or not of capillary fragility.
Per "azione ritardante" sulla ricrescita dei peli si intende un'azione che induce sia un rallentamento della velocità di crescita dei peli sia una diminuzione della quantità di peli in crescita. By "retarding action" on hair regrowth we mean an action that induces both a slowdown in the speed of hair growth and a decrease in the amount of hair growing.
Secondo la presente invenzione, le composizioni cosmetiche possono essere sotto forma di formulazioni postdepilatorie o post -epilatorie, cioè da applicare successivamente alla depilazione o all'epilazione, oppure possono essere comprese in formulazioni depilatorie. According to the present invention, the cosmetic compositions can be in the form of post-epilatory or post-epilatory formulations, i.e. to be applied after the hair removal or epilation, or they can be included in depilatory formulations.
Per "formulazioni depilatorie" si intendono formulazioni in grado di rimuovere i peli anche tramite la scissione dei legami disolfurici della cheratina, che provoca la distruzione del pelo o un indebolimento tale da consentirne una facile rimozione meccanica (mediante una spatola, una spugnetta o per semplice lavaggio con acqua). Formulazioni depilatorie convenzionali possono contenere come ingrediente attivo derivati tiolici, quali acido tioglicolico e tiolattico e loro sali con metalli alcalini e alcalinoterrosi; etanolammina tioglicato; amminoetantiolo ; acido mercaptopropionico; acido tioglicico e tioacetico; solfato di bario. By "depilatory formulations" we mean formulations capable of removing hair also through the splitting of the disulfide bonds of the keratin, which causes the destruction of the hair or a weakening such as to allow easy mechanical removal (using a spatula, a sponge or simply washing with water). Conventional depilatory formulations can contain thiol derivatives as active ingredients, such as thioglycolic and thiolactic acid and their salts with alkali and alkaline earth metals; ethanolamine thioglycate; aminoethantiol; mercaptopropionic acid; thioglycic and thioacetic acid; barium sulfate.
Per comodità, l'espressione "composizioni postdepilatorie" utilizzata di seguito indicherà composizioni sia post-depilatorie sia post-epilatorie. For convenience, the term "post-depilatory compositions" used below will refer to both post-depilatory and post-epilatory compositions.
Le composizioni dell'invenzione saranno opportunamente formulate in forma liquida, per esempio sotto forma di lozione, latte, soluzione, emulsione, o in forma solida o semi-solida , per esempio crema, pasta, gel, schiuma. A tale scopo, le composizioni dell'invenzione conterranno veicoli cosmeticamente accettabili usati convenzionalmente per la preparazione di formulazioni per uso topico, per esempio addensanti, quali gomma adragante, xantanica, gesso, argilla, ossido di magnesio, talco; chelanti, quali acido etilendiamminotetracet ico e disodio edetato; emollienti, quali alcol cetilico e stearilico, paraffina liquida, gliceril stearato, oli siliconici, oli e cere idrocarburiche ; umettanti, quali urea o 1,3-butilene glicol; emulsionanti, quali trigliceridi a catena media, polimeri dell'acido acrilico, alcol stearilico o cetilico etossilati, poliossietilene alchileteri; agenti promotori di assorbimento, quali ciclodestrani e liposomi; antiossidanti, quali ascorbil palmitato, tocoferolo; conservanti, come glicerina, propilenglicol; stabilizzanti e profumi. The compositions of the invention will be suitably formulated in liquid form, for example in the form of lotion, milk, solution, emulsion, or in solid or semi-solid form, for example cream, paste, gel, foam. For this purpose, the compositions of the invention will contain cosmetically acceptable vehicles conventionally used for the preparation of formulations for topical use, for example thickeners, such as tragacanth, xanthanum, gypsum, clay, magnesium oxide, talc; chelators, such as ethylenediaminetetraacetyl acid and edetate disodium; emollients, such as cetyl and stearyl alcohol, liquid paraffin, glyceryl stearate, silicone oils, hydrocarbon oils and waxes; humectants, such as urea or 1,3-butylene glycol; emulsifiers, such as medium chain triglycerides, acrylic acid polymers, ethoxylated stearyl or cetyl alcohol, polyoxyethylene alkyl ethers; absorption promoting agents, such as cyclodextrans and liposomes; antioxidants, such as ascorbyl palmitate, tocopherol; preservatives, such as glycerin, propylene glycol; stabilizers and perfumes.
Nel caso di composizioni depilatorie, potranno essere presenti anche agenti acceleratori di depilazione convenzionali, quali quelli a base di uree, tiouree e biguanidi . In the case of depilatory compositions, conventional hair removal accelerating agents may also be present, such as those based on ureas, thioureas and biguanides.
La presente invenzione ha inoltre per un oggetto un metodo di trattamento cosmetico volto a ritardare la crescita dei peli superflui, metodo che consiste nell <1 >applicare una quantità cosmeticamente efficace delle composizioni dell'invenzione sulla superficie del corpo sulla quale crescono i peli da eliminare. La quantità di composizione da applicare e la frequenza di applicazione varieranno a seconda della zona da trattare e delle caratteristiche personali dell<1>utilizzatore, ma generalmente saranno comprese tra 0,01 e 0,1 mi di composizione per cm di superficie cutanea, da applicare da 1 a 3 volte al giorno durante i primi tempi di trattamento, per diminuire successivamente la frequenza fino a una applicazione a giorni alterni, a seconda dei risultati ottenuti. The present invention furthermore relates to a cosmetic treatment method aimed at retarding the growth of unwanted hair, a method which consists in applying a cosmetically effective amount of the compositions of the invention on the surface of the body on which the hairs to be removed grow. . The amount of composition to be applied and the frequency of application will vary according to the area to be treated and the personal characteristics of the user, but will generally be between 0.01 and 0.1 ml of composition per cm of skin surface, from apply 1 to 3 times a day during the first treatment times, to subsequently decrease the frequency up to one application every other day, depending on the results obtained.
Sono stati effettuati test su volontarie sane di età compresa tra i 22 e i 40 anni utilizzando: Tests were performed on healthy volunteers between the ages of 22 and 40 using:
a) composizioni post-depilatorie secondo l'invenzione, da applicarsi successivamente alla rimozione dei peli superflui effettuata con metodi convenzionali; a) post-depilatory compositions according to the invention, to be applied after the removal of unwanted hair carried out with conventional methods;
b) composizioni depilatorie convenzionali, contenenti le composizioni dell'invenzione; b) conventional depilatory compositions, containing the compositions of the invention;
c) composizioni depilatorie convenzionali, non contenenti le composizioni dell'invenzione. c) conventional depilatory compositions, not containing the compositions of the invention.
Nel caso dei trattamenti con a) e b), la ricrescita completa dei peli avveniva non prima di 3 settimane, diminuendo progressivamente col perdurare del trattamento; inoltre si notava un indebolimento dei peli ricresciuti. Al contrario, nel trattamento con c), la ricrescita dei peli era completa entro 2 - 3 settimane. In the case of treatments with a) and b), the complete regrowth of the hair took place no earlier than 3 weeks, progressively decreasing as the treatment continued; furthermore there was a weakening of the regrown hairs. In contrast, in treatment with c), hair regrowth was complete within 2 - 3 weeks.
Si descrivono di seguito alcuni esempi di composizioni cosmetiche secondo l'invenzione. Some examples of cosmetic compositions according to the invention are described below.
ESEMPIO 1 EXAMPLE 1
Formulazione post-depilatoria in gel Post-depilatory gel formulation
ESTRATTO LIPOFILO DI SERENOA REPENS 2% RUSCOGENINE 0.3% -ESTRATTO DI ZANTHOXYLUM BUNGEANUM 0.5% SERENOA REPENS LIPOPHIL EXTRACT 2% RUSCOGENINE 0.3% - ZANTHOXYLUM BUNGEANUM EXTRACT 0.5%
100 g contengono: 100 g contain:
ESTRATTO LIPOFILO DI SERENOA REPENS* 2.00 g RUSCOGENINE 0.30 g ESTRATTO DI ZANTHOXYLUM BUNGEANUM** sol. 20% 0.50 g Etanolo 20.00 g SERENOA REPENS LIPOPHIL EXTRACT * 2.00 g RUSCOGENINE 0.30 g ZANTHOXYLUM BUNGEANUM EXTRACT ** sol. 20% 0.50 g Ethanol 20.00 g
Gliceri di PEG-6-Caprilico/ Caprico PEG-6-Caprylic / Capric glycers
(softigen 767-Huls) 15.00 g Propi lenglicol 10.00 g Oleth 20 (Volpo 20 - Croda) 5.00 g Dimeticone copoliolo 2.50 g Carbomer 2.00 g Trietanolammina 1.00 g Zinco ricinoleato (Tegodor HY77 - Teco) 0.20 g Mentolo 0.50 g Conservanti q.b. (softigen 767-Huls) 15.00 g Propi lenglicol 10.00 g Oleth 20 (Volpo 20 - Croda) 5.00 g Dimethicone copolyol 2.50 g Carbomer 2.00 g Triethanolamine 1.00 g Zinc ricinoleate (Tegodor HY77 - Teco) 0.20 g Menthol 0.50 g Preservatives to taste
Antiossidanti q.b. Antioxidants to taste
Acqua depurata q.b. a 100.00 g Purified water q.s. to 100.00 g
* Preparato secondo US 5,547,673. * Prepared according to US 5,547,673.
** Preparato secondo WO00/02570. ** Prepared according to WO00 / 02570.
ESEMPIO 2 EXAMPLE 2
Formulazione post -depilatoria come emulsione olio-inacqua Post-depilatory formulation as an oil-in-water emulsion
ACIDO GLICIRRETINICO COMPLESSO CON FOSFOLIPIDI 1% - SERENOA REPENS 2% - RUSCOGENINE 1% COMPLEX GLYCYRETINIC ACID WITH PHOSPHOLIPIDS 1% - SERENOA REPENS 2% - RUSCOGENINE 1%
100 g contengono: 100 g contain:
ACIDO GLICIRRETINICO COMPLESSO CON FOSFOLIPIDI* 1.00 g RUSCOGENINE** 1.00 g ESTRATTO PURIFICATO SERENOA REPENS 2.00 g Gliceril stearato (Cutina GMS-Henkel) 7.00 g Polisorbato 60 (Tween 60 - ICI) 5.00 g Propilenglicol 5.00 g COMPLEX GLYCYRETINIC ACID WITH PHOSPHOLIPIDS * 1.00 g RUSCOGENINE ** 1.00 g PURIFIED EXTRACT SERENOA REPENS 2.00 g Glyceryl stearate (Cutin GMS-Henkel) 7.00 g Polysorbate 60 (Tween 60 - ICI) 5.00 g Propylene glycol 5.00 g
Ott ildodecanolo (Eutanol G - Henkel) 4.00 g Oct ildodecanol (Eutanol G - Henkel) 4.00 g
Olio di germe di grano 3.00 g Wheat germ oil 3.00 g
PEG-5 Steroli di soia 2.00 g (Generol 122 E5 - Henkel) PEG-5 Soybean Sterols 2.00 g (Generol 122 E5 - Henkel)
Dimethicone 1.00 g Carbomer 0.60 g Tocoferolo 0.20 g Ascorbil Palmitato 0.10 g Dimethicone 1.00 g Carbomer 0.60 g Tocopherol 0.20 g Ascorbyl Palmitate 0.10 g
NaOH sol. 10% 2.00 g NaOH sol. 10% 2.00 g
EDTA Disodio 0.10 g EDTA Disodium 0.10 g
Zinco ricinoleato (Tegodor CW90-Tego) 0.20 g Conservanti q.b. Zinc ricinoleate (Tegodor CW90-Tego) 0.20 g Preservatives to taste
Profumo q.b. Perfume to taste
Acqua depurata q.b. a 100.00 g Purified water q.s. to 100.00 g
* Preparato secondo EP 0283713. * Prepared according to EP 0283713.
** Preparato secondo EP 0250953. ** Prepared according to EP 0250953.
ESEMPIO 3 EXAMPLE 3
Formulazione post-depilatoria come emulsione olio-inacqua Post-depilatory formulation as an oil-in-water emulsion
SERICOSIDE COMPLESSO CON FOSFOLIPIDI 1.5% ESTRATTO LIPOFILO DI CUCURBITA PEPO 2% - RUSCOGENINE 0.5% COMPLEX SERICOSIDE WITH PHOSPHOLIPIDS 1.5% EXTRACT LIPOFILO DI CUCURBITA PEPO 2% - RUSCOGENINE 0.5%
100 g contengono: 100 g contain:
SERICOSIDE COMPLESSO CON FOSFOLIPIDI* 1.50 g ESTRATTO LIPOFILO DI CUCURBITA PEPO 2.00 g RUSCOGENINE C 0.50 g Glicerina 30.00 g Gliceril Stearato (e) Ceteareth-20 (e) COMPLEX SERICOSIDE WITH PHOSPHOLIPIDS * 1.50 g LIPOPHYL EXTRACT OF CUCURBITA PEPO 2.00 g RUSCOGENINE C 0.50 g Glycerin 30.00 g Glyceryl Stearate (e) Ceteareth-20 (e)
Ceteareth-12 (e) Cetearil Alcol (e) Ceteareth-12 (e) Cetearyl Alcohol (e)
Cetil Palmitato (Emulgade SE- Henkel) 7.00 g Ceteareth-20 (Eumulgin B2 - Henkel) 2.00 g Dimethicone copoliolo 2.00 g Cetyl Palmitate (Emulgade SE- Henkel) 7.00 g Ceteareth-20 (Eumulgin B2 - Henkel) 2.00 g Dimethicone copolyol 2.00 g
(SF 1188 - General Eletric) (SF 1188 - General Eletric)
Zinco Ricinoleato (Tegodor CW90-Tego) 0.20 g Disodio edetato 0.10 g Tocoferolo 0.20 g Ascorbil Palmitato 0.10 g Conservanti q.b. Zinc Ricinoleate (Tegodor CW90-Tego) 0.20 g Disodium edetate 0.10 g Tocopherol 0.20 g Ascorbyl Palmitate 0.10 g Preservatives to taste
Profumo q.b. Perfume to taste
Acqua depurata q.b. a 100.00 g Purified water q.s. to 100.00 g
* Preparato secondo EP 0283713. * Prepared according to EP 0283713.
ESEMPIO 4 EXAMPLE 4
Formulazione post-depilatoria come lozione olio-in-acqua ESCINA/β-Sitosterolo COMPLESSO CON FOSFOLIPIDI 1.5 % ESTRATTO LIPOFILO DI CUCURBITA PEPO 2.0 % - ESTRATTO DI RUSCUS ACULEATUS 1.0% Post-depilatory formulation as an oil-in-water lotion ESCIN / β-Sitosterol COMPLEX WITH PHOSPHOLIPIDS 1.5% CUCURBITA LIPOFILO EXTRACT PEPO 2.0% - EXTRACT OF RUSCUS ACULEATUS 1.0%
100 g contengono: 100 g contain:
ESCINA/S-Sitosterolo COMPLESSO CON FOSFOLIPIDI* 1.50 g RUSCO ESTRATTO SECCO 1.00 g ESTRATTO LIPOFILO DI CUCURBITA PEPO 2.00 g Glicerina 5.00 g Poliisoprene (Syntesqual - Vevy) 2.50 g Isostearil isostearato (Gattefossè) 2.50 g Cetil Palmitato (Crodamol CP-Croda) 2.00 g Decil Oleato (Cetiol V - Henkel) 2.00 g Cetearil Isononanoato (Cetiol SN - Henkel) 2.00 g Polisorbato 80 (Tween 80 - ICI) 1.00 g Zinco Ricinoleato (Tegodor CW90 - Tego) 0.20 g Tocoferolo 0.20 g Ascorbil palmitato 0.10 g Disodio edetato 0.10 g Poliacrilammide (e) C13-14 isoparaffina ESCIN / S-Sitosterol COMPLEX WITH PHOSPHOLIPIDS * 1.50 g RUSCO DRY EXTRACT 1.00 g LIPOFILO EXTRACT OF CUCURBITA PEPO 2.00 g Glycerin 5.00 g Polyisoprene (Syntesqual - Vevy) 2.50 g Isostearyl isostearate (Gattefossil Palmitate) 2.00 g Crodetol Palmitate 2.50 g g Decyl Oleate (Cetiol V - Henkel) 2.00 g Cetearyl Isononanoate (Cetiol SN - Henkel) 2.00 g Polysorbate 80 (Tween 80 - ICI) 1.00 g Zinc Ricinoleate (Tegodor CW90 - Tego) 0.20 g Tocopherol 0.20 g Ascorbyl palmitate 0.10 g Disodium edetate 0.10 g Polyacrylamide (e) C13-14 isoparaffin
(e) laureth-7 (Sepigei 305- Seppie) 2.00 g Conservanti q.b. (e) laureth-7 (Sepigei 305- Cuttlefish) 2.00 g Preservatives to taste
Profumo q.b. Perfume to taste
Acqua depurata q.b. a 100.00 g * Preparato secondo EP 0283713. Purified water q.s. at 100.00 g * Prepared according to EP 0283713.
ESEMPIO 5 EXAMPLE 5
Formulazione post -depilatoria come emulsione olio-inacqua Post-depilatory formulation as an oil-in-water emulsion
ACIDO GLICIRRETINICO COMPLESSO CON FOSFOLIPIDI 1.5% COMPLESSO CON FOSFOLIPIDI DI OLIGOMERI PROCIANIDOLICI DI VITIS VINIFERA 0.5% - ESTRATTO LIPOFILO DI SERENOA REPENS 2% 100 g contengono: GLYCYRETINIC ACID COMPLEX WITH PHOSPHOLIPIDS 1.5% COMPLEX WITH OLIGOMER PHOSPHOLIPIDS PROCYANIDOLIC ACID OF VITIS VINIFERA 0.5% - LIPOPHYL EXTRACT OF SERENOA REPENS 2% 100 g contain:
ACIDO GLICIRRETINICO COMPLESSO CON FOSFOLIPIDI * 1.50 g COMPLESSO CON FOSFOLIPIDI DI OLIGOMERI PROCIANIDOLICI DI VITIS VINIFERA ** 0.50 g ESTRATTO LIPOFILO DI SERENOA REPENS 2.00 g Propilenglicol 15.00 g Olio di Jojoba modificato 5.00 g (Cetiol J600 - Henkel) GLYCYRETINIC ACID COMPLEX WITH PHOSPHOLIPIDS * 1.50 g COMPLEX WITH PHOSPHOLIPIDS OF VITIS VINIFERA PROCYANIDOL OLIGOMERS ** 0.50 g LIPOPHYL EXTRACT OF SERENOA REPENS 2.00 g Propylene glycol 15.00 g Modified Jojoba Oil 5.00 g
Cetil Alcol 5.00 g Gliceril stearato (Cutina GMS - Henkel) 5.00 g Polisorbato 60 (Tween 60 - ICI) 3.00 g Hectorite (e) idrossietilcellulosa Cetyl Alcohol 5.00 g Glyceryl stearate (Cutin GMS - Henkel) 5.00 g Polysorbate 60 (Tween 60 - ICI) 3.00 g Hectorite (e) hydroxyethylcellulose
(Betone LT - Rheox) 0.50 g Dimethicone 350 0.50 g Zinco Ricinoleato (Tegodor CW90 -Tego) 0.20 g Disodio edetato 0.10 g Tocoferolo 0.20 g Ascorbil palmitato 0.10 g Sodio Metabisolfito 0.10 g Acido citrico 0.10 g Conservanti q.b. (Betone LT - Rheox) 0.50 g Dimethicone 350 0.50 g Zinc Ricinoleate (Tegodor CW90 -Tego) 0.20 g Disodium edetate 0.10 g Tocopherol 0.20 g Ascorbyl palmitate 0.10 g Sodium Metabisulphite 0.10 g Citric acid 0.10 g Preservatives to taste
Profumo q.b. Perfume to taste
Acqua depurata q.b. a 100.00 g * Preparato secondo EP0283713. Purified water q.s. at 100.00 g * Prepared according to EP0283713.
** Preparato secondo EP0275224. ** Prepared according to EP0275224.
ESEMPIO 6 EXAMPLE 6
Formulazione post-depilatoria come lozione alcolica ACIDO 18/S-GLICIRRETINICO 0.1% - GINGKO BILOBA 1% - SERENOA R. 0.5% Post-depilatory formulation as alcoholic lotion 18 / S-GLYCYRETHIN ACID 0.1% - GINGKO BILOBA 1% - SERENOA R. 0.5%
Acido 18/β-GLICIRRETINICO 0.10 g GINGKO BILOBA ESTRATTO SECCO 1.00 g (cont. 20% saponine) 18 / β-Glycyrretinic acid 0.10 g GINGKO BILOBA DRY EXTRACT 1.00 g (contains 20% saponins)
SERENOA REPENS ESTRATTO PURIFICATO 0.50 g Ciclomethicone 10.00 g PEG-40 Olio di ricino idrogenato SERENOA REPENS PURIFIED EXTRACT 0.50 g Cyclomethicone 10.00 g PEG-40 Hydrogenated castor oil
(Cremophor RH40-BASF) 1.00 g Zinco Ricinoleato (Tegodor HY77- Tego) 0.20 g Idrossitoluene Butilato 0.05 g Profumo q.b. Alcol q.b. a 100.00 mi ESEMPIO 7 (Cremophor RH40-BASF) 1.00 g Zinc Ricinoleate (Tegodor HY77- Tego) 0.20 g Butylated hydroxytoluene 0.05 g Perfume to taste Alcohol to taste at 100.00 m EXAMPLE 7
Formulazione post-depilatoria in gel Post-depilatory gel formulation
ESTRATTO LIPOFILO DI SERENOA REPENS 2% -100 g contengono: SERENOA REPENS LIPOPHIL EXTRACT 2% -100 g contain:
ESTRATTO LIPOFILO DI SERENOA REPENS 2.00 g Etanolo 20.00 g Gliceridi PEG-6-Caprilico/Caprico SERENOA REPENS LIPOPHIL EXTRACT 2.00 g Ethanol 20.00 g PEG-6-Caprylic / Capric glycerides
(softigen 767-Huls) 15.00 g Propilenglicol 10.00 g Oleth 20 (Volpo 20 - Croda) 5.00 g Dimeticone copoliolo 2.50 g Carbomer 2.00 g Trietanolammina 1.00 g Zinco ricinoleato (Tegodor HY77 - Teco) 0.20 g Mentolo 0.50 g Conservanti q.b. (softigen 767-Huls) 15.00 g Propylene glycol 10.00 g Oleth 20 (Volpo 20 - Croda) 5.00 g Dimethicone copolyol 2.50 g Carbomer 2.00 g Triethanolamine 1.00 g Zinc ricinoleate (Tegodor HY77 - Teco) 0.20 g Menthol 0.50 g Preservatives to taste
Antiossidanti q.b. Antioxidants to taste
Acqua depurata q.b. a 100.00 g ESEMPIO 8 Purified water q.s. at 100.00 g EXAMPLE 8
Formulazione post-depilatoria come emulsione olio-inacqua Post-depilatory formulation as an oil-in-water emulsion
- ESTRATTO LIPOFILO DI CUCURBITA PEPO 2% -100 g contengono: - LIPOFILO EXTRACT OF CUCURBITA PEPO 2% -100 g contain:
ESTRATTO LIPOFILO DI CUCURBITA PEPO 2.00 g Glicerina 30.00 g Gliceril Stearato (e) Ceteareth-20 (e) LIPOFILO EXTRACT OF CUCURBITA PEPO 2.00 g Glycerin 30.00 g Glyceryl Stearate (e) Ceteareth-20 (e)
Ceteareth-12 (e) Cetearil Alcol (e) Ceteareth-12 (e) Cetearyl Alcohol (e)
Cetil Palmitato (Emulgade SE- Henkel) 7.00 g Ceteareth-20 (Eumulgin B2 - Henkel) 2.00 g Dimethicone copoliolo 2.00 g (SF 1188 - General Eletric) Cetyl Palmitate (Emulgade SE- Henkel) 7.00 g Ceteareth-20 (Eumulgin B2 - Henkel) 2.00 g Dimethicone copolyol 2.00 g (SF 1188 - General Eletric)
Zinco Ricinoleato (Tegodor CW90-Tego) 0.20 g Disodio edetato 0.10 g Tocoferolo 0.20 g Ascorbil Palmitato 0.10 g Conservanti q.b. Zinc Ricinoleate (Tegodor CW90-Tego) 0.20 g Disodium edetate 0.10 g Tocopherol 0.20 g Ascorbyl Palmitate 0.10 g Preservatives to taste
Profumo q.b. Perfume to taste
Acqua depurata q.b. a 100.00 g Purified water q.s. to 100.00 g
Claims (11)
Priority Applications (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI000628A ITMI20000628A1 (en) | 2000-03-24 | 2000-03-24 | COSMETIC COMPOSITIONS DELAYING THE GROWTH OF THE HAIR |
| RU2002125449/15A RU2002125449A (en) | 2000-03-24 | 2001-02-12 | COSMETIC COMPOSITIONS THAT HAVE A RETAINING ACTION ON REPEATED GROWTH OF UNUSED HAIR |
| CA002403744A CA2403744A1 (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| CN01806953A CN1419436A (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| JP2001570228A JP2003528123A (en) | 2000-03-24 | 2001-02-12 | Cosmetic composition having a delay effect on the regeneration of unwanted hair |
| PL01357024A PL357024A1 (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| CZ20023161A CZ20023161A3 (en) | 2000-03-24 | 2001-02-12 | Cosmetic composition |
| HU0300328A HUP0300328A2 (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| KR1020027012153A KR20020081583A (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| AU2001237375A AU2001237375A1 (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| IL15184601A IL151846A0 (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| PCT/EP2001/001522 WO2001072266A1 (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| EP01909738A EP1265586A1 (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| SK1364-2002A SK13642002A3 (en) | 2000-03-24 | 2001-02-12 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| US09/781,301 US20010033849A1 (en) | 2000-03-24 | 2001-02-13 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| US10/152,805 US20020197290A1 (en) | 2000-03-24 | 2002-05-23 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
| NO20024519A NO20024519L (en) | 2000-03-24 | 2002-09-20 | Cosmetic compositions with retarding effect on the afterglow of pubic hair |
| HK03104529.9A HK1052296A1 (en) | 2000-03-24 | 2003-06-24 | Cosmetic compositions having retarding action on the regrowth of superfluous hair |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI000628A ITMI20000628A1 (en) | 2000-03-24 | 2000-03-24 | COSMETIC COMPOSITIONS DELAYING THE GROWTH OF THE HAIR |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20000628A0 ITMI20000628A0 (en) | 2000-03-24 |
| ITMI20000628A1 true ITMI20000628A1 (en) | 2001-09-24 |
Family
ID=11444627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT2000MI000628A ITMI20000628A1 (en) | 2000-03-24 | 2000-03-24 | COSMETIC COMPOSITIONS DELAYING THE GROWTH OF THE HAIR |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20010033849A1 (en) |
| EP (1) | EP1265586A1 (en) |
| JP (1) | JP2003528123A (en) |
| KR (1) | KR20020081583A (en) |
| CN (1) | CN1419436A (en) |
| AU (1) | AU2001237375A1 (en) |
| CA (1) | CA2403744A1 (en) |
| CZ (1) | CZ20023161A3 (en) |
| HK (1) | HK1052296A1 (en) |
| HU (1) | HUP0300328A2 (en) |
| IL (1) | IL151846A0 (en) |
| IT (1) | ITMI20000628A1 (en) |
| NO (1) | NO20024519L (en) |
| PL (1) | PL357024A1 (en) |
| RU (1) | RU2002125449A (en) |
| SK (1) | SK13642002A3 (en) |
| WO (1) | WO2001072266A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2832418B1 (en) * | 2001-11-16 | 2005-06-24 | Fabre Pierre Dermo Cosmetique | PROCESS FOR THE PREPARATION OF A HYDROLYZED COURT OIL, HYDROLYZED COURT OIL WHICH CAN BE OBTAINED BY THIS PROCESS AND USE THEREOF |
| FR2836383B1 (en) * | 2002-02-26 | 2004-10-15 | Fabre Pierre Dermo Cosmetique | USE OF NEORUSCIN FOR THE PREPARATION OF A HAIR COMPOSITION FOR THE TREATMENT OF ALOPECIA |
| JP5070434B2 (en) | 2004-01-16 | 2012-11-14 | ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス | Uses of extracts of the genus Calyceae |
| US7875650B2 (en) * | 2004-02-03 | 2011-01-25 | Yale University | Compounds and methods to increase anti-P-glycoprotein activity of baicalein by alkylation on the A ring |
| US20050260152A1 (en) * | 2004-05-03 | 2005-11-24 | Jaghab Khalil C | Hair growth composition |
| DE102004024463A1 (en) * | 2004-05-14 | 2005-12-08 | Phenion Gmbh & Co. Kg | Use of ammonium salts of glycyrrhizic acid and glycyrrhetinic acid for epilation |
| JP4630102B2 (en) * | 2005-03-30 | 2011-02-09 | 株式会社ナリス化粧品 | Hyaluronic acid production promoter and cosmetics containing the same |
| JPWO2006123529A1 (en) * | 2005-05-18 | 2008-12-25 | 東亞合成株式会社 | Membrane electrode assembly and direct liquid fuel fuel cell |
| EP1726297B1 (en) * | 2005-05-23 | 2010-08-18 | Reckitt Benckiser (UK) Limited | Composition comprising wortmannin and its topical use for reducing human hair growth |
| EP1937364A2 (en) * | 2005-09-16 | 2008-07-02 | Reckitt Benckiser (UK) Limited | Improvements in or relatimg to cosmetic compositions |
| US7727516B2 (en) * | 2006-02-28 | 2010-06-01 | The Procter & Gamble Company | Reduction of hair growth |
| WO2007115840A1 (en) * | 2006-04-07 | 2007-10-18 | Delgado Acarreta Raul | Cosmetic composition for an autonomus shave |
| EP1882473A1 (en) * | 2006-07-28 | 2008-01-30 | Indena S.P.A. | Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs |
| DE102008012988A1 (en) | 2008-03-07 | 2009-09-10 | S.W. Patentverwertungs Ltd. | Composition and uses for influencing hair growth |
| JP5654214B2 (en) * | 2008-06-04 | 2015-01-14 | 丸善製薬株式会社 | Hair suppressant and skin cosmetic for hair suppression |
| GB201110132D0 (en) * | 2011-06-16 | 2011-07-27 | Reckitt & Colman Overseas | compositions |
| ES2412506B1 (en) * | 2011-12-23 | 2014-03-26 | Laboratorios Viñas S.A. | Dermatological composition for the topical treatment of rosacea and corresponding procedure and use |
| CN102772338B (en) * | 2012-08-17 | 2013-06-26 | 珀莱雅化妆品股份有限公司 | Anti-black eye lipid nanoparticle emulsion and preparation method thereof |
| ES2610208B1 (en) * | 2015-10-22 | 2018-02-07 | Innovativehealth Group, S.L. | COSMETIC FORMULATION OF TOPIC USE FOR THE CARE OF AOPIC SKIN |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL120128A0 (en) * | 1997-02-03 | 1997-06-10 | Barr Ehud | Compositions for the treatment of androgenetic alopecia and hirsutism |
| FR2791255B1 (en) * | 1999-03-26 | 2003-05-16 | Greentech Sa | PLANT COMPLEX ENTERING INTO COSMETIC AND DERMOPHARMACEUTICAL COMPOSITIONS LIMITING THE DEVELOPMENT OF HAIR BULB, STIMULATING THE HAIR SYSTEM AND USED FOR THE TREATMENT OF SEBORRHEIC SKIN |
-
2000
- 2000-03-24 IT IT2000MI000628A patent/ITMI20000628A1/en unknown
-
2001
- 2001-02-12 JP JP2001570228A patent/JP2003528123A/en active Pending
- 2001-02-12 IL IL15184601A patent/IL151846A0/en unknown
- 2001-02-12 AU AU2001237375A patent/AU2001237375A1/en not_active Abandoned
- 2001-02-12 KR KR1020027012153A patent/KR20020081583A/en not_active Application Discontinuation
- 2001-02-12 CA CA002403744A patent/CA2403744A1/en not_active Abandoned
- 2001-02-12 PL PL01357024A patent/PL357024A1/en unknown
- 2001-02-12 RU RU2002125449/15A patent/RU2002125449A/en not_active Application Discontinuation
- 2001-02-12 CZ CZ20023161A patent/CZ20023161A3/en unknown
- 2001-02-12 SK SK1364-2002A patent/SK13642002A3/en unknown
- 2001-02-12 EP EP01909738A patent/EP1265586A1/en not_active Withdrawn
- 2001-02-12 CN CN01806953A patent/CN1419436A/en active Pending
- 2001-02-12 WO PCT/EP2001/001522 patent/WO2001072266A1/en not_active Application Discontinuation
- 2001-02-12 HU HU0300328A patent/HUP0300328A2/en unknown
- 2001-02-13 US US09/781,301 patent/US20010033849A1/en not_active Abandoned
-
2002
- 2002-09-20 NO NO20024519A patent/NO20024519L/en not_active Application Discontinuation
-
2003
- 2003-06-24 HK HK03104529.9A patent/HK1052296A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2002125449A (en) | 2004-03-20 |
| CN1419436A (en) | 2003-05-21 |
| HK1052296A1 (en) | 2003-09-11 |
| CZ20023161A3 (en) | 2003-02-12 |
| ITMI20000628A0 (en) | 2000-03-24 |
| NO20024519L (en) | 2002-11-25 |
| JP2003528123A (en) | 2003-09-24 |
| US20010033849A1 (en) | 2001-10-25 |
| IL151846A0 (en) | 2003-04-10 |
| AU2001237375A1 (en) | 2001-10-08 |
| PL357024A1 (en) | 2004-07-12 |
| WO2001072266A1 (en) | 2001-10-04 |
| CA2403744A1 (en) | 2001-10-04 |
| HUP0300328A2 (en) | 2003-08-28 |
| NO20024519D0 (en) | 2002-09-20 |
| EP1265586A1 (en) | 2002-12-18 |
| KR20020081583A (en) | 2002-10-28 |
| SK13642002A3 (en) | 2003-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI20000628A1 (en) | COSMETIC COMPOSITIONS DELAYING THE GROWTH OF THE HAIR | |
| TW201628628A (en) | Composition comprising ginseng extract with enhanced ginsenoside content as active ingredient | |
| JP7275103B2 (en) | Novel cosmetic use of Nephelium lapaceum extract | |
| US20070081968A1 (en) | Agent for inducing hair growth containing extracts of saw palmetto and swertia | |
| US9622963B2 (en) | Methods for stimulating growth and preventing loss of human hair | |
| JP6682600B2 (en) | Use to enhance hair quality using blackberry extract | |
| US20060159714A1 (en) | Use of an antioxidant in a dermatological and/or cosmetic composition | |
| JP2000229834A (en) | Cosmetic | |
| JPH03188019A (en) | Testosterone-5alpha-reductase inhibitor | |
| JPH06271452A (en) | Skin cosmetic containing extract of plant of cactuses | |
| US20020197290A1 (en) | Cosmetic compositions having retarding action on the regrowth of superfluous hair | |
| KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
| KR20030031697A (en) | Cosmetic Compositions Comprising Extract from Peach Blossom for Skin Whitening | |
| JPS643125A (en) | Testosterone 5alpha-reductase inhibitor | |
| KR100909729B1 (en) | Cosmetic composition for preventing and improving acne containing Namsil extract | |
| JPH0987148A (en) | Hair growing composition | |
| RU2183954C1 (en) | Cosmetic agent for complex skin care and method of its application | |
| KR101065609B1 (en) | Body hair growth inhibitor | |
| JPH0920623A (en) | Hair growing agent | |
| JP3105312B2 (en) | Cosmetics | |
| KR20220034272A (en) | Composition for preventing hair loss or promoting hair growth | |
| KR20120009915A (en) | Composition of skin external application for improving acne and alopecia containing Oldenlandia Diffusa Willd extracts | |
| KR20090027295A (en) | The cosmetic composition for moisturizing of skin containing the thymus quinquecostatus extracts | |
| JP2000016928A (en) | Antiperspirant | |
| JPH07215826A (en) | Hair tonic |